Search

Your search keyword '"Daniele Altomare"' showing total 92 results

Search Constraints

Start Over You searched for: Author "Daniele Altomare" Remove constraint Author: "Daniele Altomare"
92 results on '"Daniele Altomare"'

Search Results

1. Amyloid-PET imaging predicts functional decline in clinically normal individuals

2. Plasma biomarkers increase diagnostic confidence in patients with Alzheimer’s disease or frontotemporal lobar degeneration

Catalog

Books, media, physical & digital resources

3. Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study

4. Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design

5. The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact

6. Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6

7. Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6

8. Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6

9. Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6

10. Dementia risk communication. A user manual for Brain Health Services—part 3 of 6

11. Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6

12. Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design

13. Medial temporal lobe atrophy and posterior atrophy scales normative values

16. Plasma biomarkers for Alzheimer’s disease: a field-test in a memory clinic

17. Dementia prevention in memory clinics: recommendations from the European task force for brain health services

18. The taxonomy of subjective cognitive decline: proposal and first clinical evidence from the Geneva memory clinic cohort

19. The probabilistic model of Alzheimer disease

20. The Amyloid Imaging for the Prevention of Alzheimer's Disease Consortium: A European collaboration with a global impact

21. Analysis of Psychological Symptoms Following Disclosure of Amyloid–Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline

22. Feasibility of a standard cognitive assessment in European academic memory clinics

23. Three‐Objects‐Three‐Places Test: Association with Alzheimer’s Disease Biomarkers

24. Resistance, brain and cognitive resilience to ATN in a memory clinic population

25. Steps towards the implementation of amyloid‐PET in memory clinics: AMYPAD Diagnostic and Patient Management Study

26. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease

27. Ultrasound-Guided Meniscal Injection of Autologous Growth Factors: A Brief Report

28. Quantification of [

29. Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives

30. Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design

31. Biologic agents to optimize outcomes following ACL repair and reconstruction: A systematic review of clinical evidence

32. High survivorship rate and good clinical outcomes at mid-term follow-up for lateral UKA: a systematic literature review

34. Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe

35. Description of a European memory clinic cohort undergoing amyloid-PET: the AMYPAD-DPMS

36. Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population:The ABIDE project

37. Towards fingerprinting and identifiability within the Alzheimer’s continuum using resting‐state functional connectivity

39. Applying the ATN scheme in a memory clinic population

40. The Clinical Use of Alzheimer’s Biomarkers in Patients With Mild Cognitive Impairment: A European Alzheimer’s Disease Consortium Survey

41. The reliability of adductor tubercle as an anatomical landmark for joint line restoration in revision knee arthroplasty: a systematic review

42. Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6

43. Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study

44. Scaffolds for Cartilage Repair

45. Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison

46. Long sports career and satisfactory clinical outcomes after Meniscal Allograft Transplantation (MAT) in young professional athletes involved in strenuous sports

47. Baseline features of the AMYPAD Diagnostic and Patient Management Study (DPMS) participants

48. Impact of the disclosure of amyloid‐PET results to patients with subjective cognitive decline: the AMYPAD Diagnostic and Patient Management Study (DPMS)

49. Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): Retrospective analyses on the Geneva Memory Clinic cohort

50. Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies